Welcome to LookChem.com Sign In|Join Free
  • or
(2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is a tertiary butyl ester of a pyridinecarboxylic acid derivative. It features a pyridine ring with a hydroxyl group and a hydroxymethyl group attached to the third carbon of the pyridine ring. (2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is utilized as a building block in organic synthesis and pharmaceutical research, and it may have potential applications in the development of new drugs, pesticides, or other bioactive compounds.
Used in Pharmaceutical Research:
(2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is used as a building block for the development of new drugs due to its unique chemical structure and potential bioactivity.
Used in Organic Synthesis:
In the field of organic synthesis, (2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is used as a key intermediate for the synthesis of complex organic molecules.
Used in Pesticide Development:
(2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is used as a starting material in the research and development of new pesticides, potentially offering novel modes of action or enhanced efficacy.
Used in Bioactive Compound Development:
(2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER is also used in the development of bioactive compounds for various applications, including but not limited to, medical, agricultural, and industrial uses, due to its unique structural features and potential for interaction with biological targets.

505085-66-5

Post Buying Request

505085-66-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

505085-66-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 505085-66-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,5,0,8 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 505085-66:
(8*5)+(7*0)+(6*5)+(5*0)+(4*8)+(3*5)+(2*6)+(1*6)=135
135 % 10 = 5
So 505085-66-5 is a valid CAS Registry Number.

505085-66-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-(2S,3R)-3-hydroxy-2-(hydroxymethyl)-3,6-dihydro-2H-pyridine-1-carboxylic tert-butyl ester

1.2 Other means of identification

Product number -
Other names (2S,3R)-1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-3-HYDROXY-2-(HYDROXYMETHYL)-, 1,1-DIMETHYLETHYL ESTER

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:505085-66-5 SDS

505085-66-5Relevant academic research and scientific papers

Expeditious synthesis of a common intermediate of L-1-deoxyallonojirimycin and L- 1-deoxymannoj irimycin

Ferreira, J. Franck,Botuha, Candice,Chemla, Fabrice,Perez-Luna, Alejandro

, p. 2238 - 2241 (2009)

The expeditious synthesis of a common intermediate of L- 1deoxyallonojirimycin (L-allo-DNJ) and L-1-deoxymannojirimycin (L-marano-DNJ) is reported. This intermediate is obtained in highly diastereo- and enantioselectivity with 38.4% overall yield in six s

Biological properties of D- and L-1-deoxyazasugars

Kato, Atsushi,Kato, Noriko,Kano, Erika,Adachi, Isao,Ikeda, Kyoko,Yu, Liang,Okamoto, Tadashi,Banba, Yasunori,Ouchi, Hidekazu,Takahata, Hiroki,Asano, Naoki

, p. 2036 - 2044 (2005)

L-Enantiomers of 1-deoxynojirimycin (DNJ), 1-deoxymannojirimycin (manno-DNJ), 1-deoxyallonojirimycin (allo-DNJ), 1-deoxyaltronojirimycin (altro-DNJ), 1-deoxygalactonojirimycin (galacto-DNJ), 1-deoxygulonojirimycin (gulo-DNJ), and 1-deoxyidonojirimycin (ido-DNJ) were prepared according to prior methods for the D-enantiomers. These enantiospecific syntheses established unambiguously the absolute configuration of naturally occurring DNJ, manno-DNJ, allo-DNJ, altro-DNJ, and gulo-DNJ. Although D-DNJ and D-galacto-DNJ are known to be powerful competitive inhibitors of α-glucosidase and α-galactosidase, respectively, with Ki values in the nM range, L-DNJ and L-galacto-DNJ were noncompetitive inhibitors of α-glucosidase and α-galactosidase, respectively, with Ki values in the μM range. However, the azasugar mimicking the structure of the terminal sugar moiety of the natural substrate is not always an inhibitor of the glycosidase responsible for the hydrolysis. D-manno-DNJ is known as a much better inhibitor of α-L-fucosidase than α-mannosidase, while L-allo-DNJ was a better inhibitor than D-manno-DNJ of α-mannosidase. L-galacto-DNJ can be regarded as the 6-hydroxylated derivative of deoxyfuconojirimycin (DFJ), which is a powerful inhibitor of α-L-fucosidase with a Ki value in the nM range. However, this replacement of the methyl group in DFJ by a hydroxymethyl group reduced its affinity by about 50-fold. This suggests that there is a hydrophobic region in or around the active site of α-L-fucosidase. It has been found that inhibitors of human lysosomal glycosidases have therapeutic potential for the corresponding lysosomal storage diseases (Nat. Med. 1999, 5, 112; Proc. Natl. Acad. Sci. USA, 2002, 99, 15428). Inhibition of human lysosomal glycosidases by the 1-deoxyazasugars synthesized was investigated. D-galacto-DNJ is a potent inhibitor of lysosomal α-galactosidase (IC 50 = 90 nM) and is now being evaluated preclinically for its potential use in Fabry disease, while D-DNJ inhibiting α-glucosidase (IC50 = 40 nM) potently does not appear to become a potential therapeutic agent because of additional inhibitory activity toward glycoprotein processing α-glucosidases. On the other hand, although L-allo-DNJ is a moderate inhibitor of α-mannosidase (IC50 = 64 μM), it may become a key compound for the drug design of potential therapeutic agents for α-mannosidosis.

Chiral disubstituted piperidinyl ureas: A class of dual diacylglycerol lipase-α and ABHD6 inhibitors

Deng, Hui,Van Der Wel, Tom,Van Den Berg, Richard J.B.H.N.,Van Den Nieuwendijk, Adrianus M.C.H.,Janssen, Freek J.,Baggelaar, Marc P.,Overkleeft, Hermen S.,Van Der Stelt, Mario

supporting information, p. 982 - 988 (2017/07/12)

Inhibitors of diacylglycerol lipases and α,β-hydrolase domain containing protein 6 (ABHD6) are potential leads for the development of therapeutic agents for metabolic and neurodegenerative disorders. Here, we report the enantioselective synthesis and structure activity relationships of triazole ureas featuring chiral, hydroxylated 2-benzylpiperidines as dual inhibitors of DAGLα and ABHD6. The chirality of the carbon bearing the C2 substituent, as well as the position of the hydroxyl (tolerated at C5, but not at C3) has profound influence on the inhibitory activity of both DAGLα and ABHD6, as established using biochemical assays and competitive activity-based protein profiling on mouse brain extracts.

A general approach to the synthesis of 1-deoxy-L-iminosugars

Guaragna, Annalisa,D'Errico, Stefano,D'Alonzo, Daniele,Pedatella, Silvana,Palumbo, Giovanni

, p. 3473 - 3476 (2008/02/11)

A stereoselective procedure for the preparation of non-naturally occurring deoxy iminosugars belonging to L-series has been developed. The synthesis involves the construction of the key intermediate bicycle pyperidine 8, available in few steps by the coup

Diastereoselective route to piperidine and indolizidine scaffolds from enantiopure vinylsulfinyl-containing amino alcohols

Montoro, Raul,Marquez, Francesc,Llebaria, Amadeu,Delgado, Antonio

, p. 217 - 223 (2007/10/03)

A new route to functionalized piperidine and indolizidine scaffolds, based on the diastereoselective intramolecular Michael cyclization of vinylsulfinyl-containing amino alcohols 1-3, has been developed. Pyrolytic elimination of the resulting cycloadducts resulted in the regioselective formation of the corresponding tetrahydropyridines and indolizidines. The observed regiochemical course of this process can be explained mainly in terms of the steric bias imposed by the disposition of the arylsulfinyl group and the concerted syn mechanism accepted for this kind of elimination. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 505085-66-5